African countries are being backed to develop their own manufacturing capacity for next-generation HIV prevention medicines in a move aimed at reducing reliance on overseas drugmakers.
Manufacturers in Uganda, Kenya and South Africa are to receive support from global health agency Unitaid to strengthen African production of HIV prevention products.